Search

everythinglearnresearchcommunity

for

Search:↓

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Patients with alopecia areata in the UK face barriers to care, needing better-defined pathways and more education for general practitioners.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

Alopecia Areata affects both genders almost equally, mostly on the scalp, with common signs like yellow dots and exclamation mark hairs, especially in young people.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Patients with anxiety or depression report more severe alopecia areata.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Changes in skin bacteria may relate to alopecia areata severity.

Alopecia areata significantly affects patients' lives, causing physical, psychological, social, and financial challenges.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.